{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:10:59Z","timestamp":1789593059022,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012277"],"award-info":[{"award-number":["2024A1515012277"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2023YFF0724202"],"award-info":[{"award-number":["2023YFF0724202"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172080"],"award-info":[{"award-number":["82172080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijbiomac.2025.148933","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:55:31Z","timestamp":1762764931000},"page":"148933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P2","title":["Self-amplifying mRNA nanovaccine encoding GM-CSF-fused HPV16 E7 enhances immunogenicity and therapeutic efficacy against cervical cancer"],"prefix":"10.1016","volume":"333","author":[{"given":"Guibin","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148933_bb0005","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0010","article-title":"Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148933_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19061706","article-title":"High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis","volume":"19","author":"Yeo-Teh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148933_bb0020","first-page":"637","article-title":"Human papilloma virus: apprehending the link with carcinogenesis and unveiling new research avenues","volume":"52","author":"Boda","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148933_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.currproblcancer.2018.03.003","article-title":"HPV: molecular pathways and targets","volume":"42","author":"Gupta","year":"2018","journal-title":"Curr. Probl. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ygyno.2019.03.253","article-title":"Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population","volume":"154","author":"Giuliano","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148933_bb0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","article-title":"Global cancer in women: burden and trendsGlobal cancer in women: burden and trends","volume":"26","author":"Torre","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148933_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jmcb\/mjae046","article-title":"Targeting HPV for the prevention, diagnosis, and treatment of cervical cancer","volume":"16","author":"Ni","year":"2025","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.55.091902.103520","article-title":"Human papillomavirus vaccines and prevention of cervical cancer","volume":"55","author":"Jansen","year":"2004","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-024-09680-6","article-title":"Understanding the HPV associated cancers: a comprehensive review","volume":"51","author":"Balhara","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2019.11.039","article-title":"Human papillomavirus vaccine against cervical cancer: opportunity and challenge","volume":"471","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-4542-0_1","article-title":"Current landscape of therapeutic cancer vaccines","volume":"2926","author":"Rosenthal","year":"2025","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148933_bb0065","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.ymthe.2025.03.060","article-title":"The advent of clinical self-amplifying RNA vaccines","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148933_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9040390","article-title":"mRNA-based vaccines","volume":"9","author":"Kowalzik","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.coviro.2020.08.003","article-title":"A new generation of vaccines based on alphavirus self-amplifying RNA","volume":"44","author":"Ballesteros-Briones","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0080","first-page":"1","article-title":"Self-amplifying mRNA vaccines: mode of action, design, development and optimization","volume":"103341","author":"Pourseif","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148933_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v17040566","article-title":"Self-amplifying RNA: advantages and challenges of a versatile platform for vaccine development","volume":"17","author":"Vallet","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113900","article-title":"Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across","volume":"176","author":"Minnaert","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22010323","article-title":"Role of host-mediated post-translational modifications (PTMs) in RNA virus pathogenesis","volume":"22","author":"Kumar","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00501","article-title":"Modulation of APC function and anti-tumor immunity by anti-cancer drugs","volume":"6","author":"Martin","year":"2015","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148933_bb0105","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/978-1-4615-1971-3_127","article-title":"Vaccine adjuvancy: a new potential area of development for GM-CSF","volume":"378","author":"Taglietti","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148933_bb0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/cmi.2017.105","article-title":"Revisiting GM-CSF as an adjuvant for therapeutic vaccines","volume":"15","author":"Zhao","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s40824-023-00430-6","article-title":"GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model","volume":"27","author":"Dai","year":"2023","journal-title":"Biomater. Res."},{"issue":"33","key":"10.1016\/j.ijbiomac.2025.148933_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201902575","article-title":"Fast and efficient CRISPR\/Cas9 genome editing in vivo enabled by bioreducible lipid and messenger RNA nanoparticles","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.148933_bb0130","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1016\/j.jmb.2014.10.021","article-title":"The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb","volume":"426","author":"Jansma","year":"2014","journal-title":"J. Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.148933_bb0135","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.virol.2013.08.017","article-title":"Nuclear import of high risk HPV16 E7 oncoprotein is mediated by its zinc-binding domain via hydrophobic interactions with Nup62","volume":"446","author":"Eberhard","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0140","first-page":"1","article-title":"Self-replicating RNA nanoparticle vaccine elicits protective immune responses against SARS-CoV-2","author":"Lin","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148933_bb0145","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1158\/2326-6066.CIR-14-0115","article-title":"Immunomodulatory roles of lymphatic vessels in cancer progression","volume":"2","author":"Swartz","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148933_bb0150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41551-019-0378-3","article-title":"Visualization of early events in mRNA vaccine delivery in non-human primates via PET-CT and near-infrared imaging","volume":"3","author":"Lindsay","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/imm.12714","article-title":"Retinoic acid-inducible gene I (RIG-I)-like receptors (RLR s) in fish: current knowledge and future perspectives","volume":"151","author":"Chen","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0160","series-title":"Interferons and Their Role in Viral Infection, Dynamics of Immune Activation in Viral Diseases","first-page":"61","author":"George","year":"2020"},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.148933_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms232314915","article-title":"IFN\u03b2-induced CXCL10 chemokine expression is regulated by Pellino3 ligase in monocytes and macrophages","volume":"23","author":"Makuch","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0170","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148933_bb0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2018.06.012","article-title":"Plasmacytoid dendritic cell in immunity and cancer","volume":"322","author":"Mitchell","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cellimm.2015.09.011","article-title":"Tolerance and immune suppression in the tumor microenvironment","volume":"299","author":"Ostrand-Rosenberg","year":"2016","journal-title":"Cell. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148933_bb0190","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.intimp.2011.01.003","article-title":"Myeloid derived suppressor cells in human diseases","volume":"11","author":"Greten","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01512","article-title":"Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice","volume":"9","author":"Jayasingam","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0200","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/nyas.13625","article-title":"Regulatory T cells: a potential target in cancer immunotherapy","volume":"1417","author":"Shitara","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.148933_bb0205","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1158\/0008-5472.CAN-05-3755","article-title":"CD80 in immune suppression by mouse ovarian carcinoma\u2013associated Gr-1+ CD11b+ myeloid cells","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148933_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers14122884","article-title":"The role of immune modulatory cytokines in the tumor microenvironments of head and neck squamous cell carcinomas","volume":"14","author":"Kondoh","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/jir.2018.0019","article-title":"Cytokines in the treatment of cancer","volume":"39","author":"Conlon","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0220","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/PL00014051","article-title":"The critical role of Th1-dominant immunity in tumor immunology","volume":"46","author":"Nishimura","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-016-0293-9","article-title":"Perspectives for therapeutic HPV vaccine development","volume":"23","author":"Yang","year":"2016","journal-title":"J. Biomed. Sci."},{"issue":"555","key":"10.1016\/j.ijbiomac.2025.148933_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates","volume":"12","author":"Erasmus","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148933_bb0235","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1099\/jgv.0.000249","article-title":"Alphavirus RNA synthesis and non-structural protein functions","volume":"96","author":"Rupp","year":"2015","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148933_bb0240","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ni0504-460","article-title":"Vaccine development strategies for improving immunization: the role of modern immunology","volume":"5","author":"Levine","year":"2004","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148933_bb0245","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/imt-2016-0141","article-title":"Recent progress in GM-CSF-based cancer immunotherapy","volume":"9","author":"Yan","year":"2017","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","article-title":"Cytokines in cancer","volume":"43","author":"Kureshi","year":"2025","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148933_bb0255","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2010.08.012","article-title":"Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems","volume":"147","author":"Mohanan","year":"2010","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148933_bb0260","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bit.26083","article-title":"Impact of dose, route, and composition on the immunogenicity of immune polyelectrolyte multilayers delivered on gold templates","volume":"114","author":"Zhang","year":"2017","journal-title":"Biotechnol. Bioeng."},{"issue":"15\u201316","key":"10.1016\/j.ijbiomac.2025.148933_bb0265","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0264-410X(98)00410-1","article-title":"Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents","volume":"17","author":"Mark","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148933_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-10-3","article-title":"Improvement of different vaccine delivery systems for cancer therapy","volume":"10","author":"Bolhassani","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148933_bb0275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2024.07.078","article-title":"Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity","volume":"374","author":"Bathula","year":"2024","journal-title":"J. Control. Release"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025094905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025094905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:20:55Z","timestamp":1766089255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025094905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":55,"alternative-id":["S0141813025094905"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148933","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-amplifying mRNA nanovaccine encoding GM-CSF-fused HPV16 E7 enhances immunogenicity and therapeutic efficacy against cervical cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"148933"}}